Related Experiment Video

Updated: Aug 28, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.7K

miR-92a-3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis

Zhi-Hao Yu1,2,3,4, Zhao-Hui Chen1,2,3,4, Guang-Lei Zhou1,2,3,4

  • 1The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.

Thoracic Cancer
|September 13, 2022
PubMed
Abstract

Insights

MicroRNA-92a-3p promotes breast cancer by inhibiting the tumor suppressor Krüppel-like factor 2 (KLF2). This pathway involves KLF2 suppressing Baculoviral IAP Repeat Containing 5 (BIRC5), offering new therapeutic targets.

Area of Science:

  • Molecular Oncology
  • Gene Regulation
  • Cancer Biology

Background:

  • Breast cancer is a leading global malignancy in women.
  • Gene dysregulation plays a crucial role in breast cancer development.
  • Krüppel-like factors (KLFs) are implicated in breast cancer, with KLF2 acting as a tumor suppressor.

Purpose of the Study:

  • To elucidate the molecular mechanism by which KLF2 functions as a tumor suppressor in breast cancer.
  • To identify upstream regulators and downstream targets of KLF2 in breast cancer.
  • To investigate the role of the miR-92a-3p/KLF2/BIRC5 axis in breast cancer pathogenesis.

Main Methods:

  • Bioinformatic analysis using starBase v.3.0 to identify microRNA regulators.
  • In vitro and in vivo assays to confirm the regulation of KLF2 by miR-92a-3p.
  • Chromatin immunoprecipitation (ChIP) assay, dual-luciferase reporter assays, quantitative real-time PCR, and Western blot to validate molecular interactions.

Main Results:

  • miR-92a-3p was identified as a direct inhibitor of KLF2 by binding to its 3'-untranslated region (3'-UTR).
  • KLF2 was found to transcriptionally suppress the expression of Baculoviral IAP Repeat Containing 5 (BIRC5).
  • The miR-92a-3p/KLF2/BIRC5 signaling pathway was established in breast cancer.

Conclusions:

  • The study uncovered the miR-92a-3p/KLF2/BIRC5 axis as a key mechanism in breast cancer development.
  • miR-92a-3p acts as an oncogene by inhibiting the tumor-suppressive function of KLF2.
  • This axis presents potential therapeutic strategies for breast cancer treatment.
Keywords:
BIRC5KLF2breast cancermiR-92a-3pproliferation

More Related Videos

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

41.4K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.3K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K